Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN103820416B reveals high-stereoselectivity ester hydrolase for chiral synthesis. Enhances purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111454222B reveals a metal-free CO2 fixation route for quinazolinediones. This method offers high yields, mild conditions, and significant cost reduction potential.
Patent CN112079781B reveals a safer synthesis route for 5-bromo-1-methyl-1H-pyrazol-3-amine, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Advanced solid-phase synthesis of antibacterial cyclic hexapeptide Thermoactinoamide A. Patent CN108440654B offers high yield, scalable production for reliable pharmaceutical suppliers.
Novel preparation method for Enzalutamide CAS 915087-33-1 offering high yield and purity without column chromatography for reliable pharmaceutical intermediate supply.
Advanced base-catalyzed synthesis of Fexofenadine intermediate CN101585762A offers high purity, reduced costs, and scalable manufacturing for global pharmaceutical supply chains.
Patent CN102391243B details a high-yield route for atorvastatin side chain intermediates, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN112521352A details a novel route for (R)-4-propyl-dihydrofuran-2-one. This method offers cost reduction in API manufacturing and scalable production.
Patent CN115611769A reveals a continuous flow method for sartanbiphenyl. Enhance safety and yield in API intermediate manufacturing with this novel Kumada coupling approach.
Novel alcohol-ketone-water recrystallization achieves 99% purity for ketophenylalanine calcium intermediates reducing downstream refinement needs and ensuring supply chain stability effectively
Patent CN112961086B details a novel Rh-catalyzed one-step synthesis of 2-methylene-1-indanone derivatives, offering significant cost reduction in API manufacturing and scalable production.
Patent CN115232013B enables mild copper-catalyzed reduction. Offers high purity and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN102548958A reveals a safer, high-yield synthesis for anticancer tricyclic derivatives, offering significant cost reduction and supply chain reliability for API manufacturing.
Novel method replaces Claisen condensation for high-purity dioxane acetate intermediates. Significantly reduces production costs and improves scalability for global statin manufacturers.
Patent CN101575311B discloses a cost-effective melatonin synthesis from 4-aminobutyric acid. This novel method ensures high purity and scalable production for global supply chains.
Patent CN103408532A details a green oxidation method for PPIs using ion exchange resin and hydrogen peroxide, offering high purity and scalable manufacturing advantages.
Patent CN102030798A details a novel triflic acid salting method for Abiraterone Acetate, offering superior filtration and purity over traditional mesylate routes for API manufacturers.
Advanced patent CN110590606A details efficient asymmetric hydrogenation and enzymatic reduction for high-purity pharmaceutical intermediates, ensuring cost-effective and scalable supply chain solutions.
Patent CN116730849A reveals a high-yield enzymatic route for HIV inhibitor intermediates. Achieve superior purity and scalable supply chain reliability.
Patent CN106032380A reveals a one-step midazolam production method. Discover cost reduction and supply chain advantages for pharmaceutical intermediates manufacturing.